Literature DB >> 28812140

Blistering eruptions in Henoch-Schönlein syndrome: more common than assumed.

Valérie Peeters1, Linda De Raeve2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28812140     DOI： 10.1007/s00431-017-2990-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  5 in total

Review 1.  Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature.

Authors:  F T Saulsbury
Journal:  Medicine (Baltimore)       Date:  1999-11       Impact factor: 1.889

Review 2.  Blistering eruptions in childhood Henoch-Schönlein syndrome: systematic review of the literature.

Authors:  Vera Ramelli; Sebastiano A G Lava; Giacomo D Simonetti; Mario G Bianchetti; Gian Paolo Ramelli; Gregorio P Milani
Journal:  Eur J Pediatr       Date:  2017-02-04       Impact factor: 3.183

3.  Schönlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulonephritis in a retrospective study of 57 cases.

Authors:  E Tancrede-Bohin; S Ochonisky; M D Vignon-Pennamen; B Flageul; P Morel; M Rybojad
Journal:  Arch Dermatol       Date:  1997-04

4.  Bullous lesions in Henoch Schönlein Purpura as indication to start systemic prednisone.

Authors:  S L Den Boer; Sgma Pasmans; N M Wulffraat; N L Ramakers-Van Woerden; M T Bousema
Journal:  Acta Paediatr       Date:  2009-01-05       Impact factor: 2.299

Review 5.  Management of haemorrhagic bullous lesions in Henoch-Schonlein purpura: is there any consensus?

Authors:  Sabiha Kausar; Aparna Yalamanchili
Journal:  J Dermatolog Treat       Date:  2009       Impact factor: 3.359
  5 in total
  2 in total

Review 1.  Multisystemic manifestations of IgA vasculitis.

Authors:  Lina Du; Panpan Wang; Chang Liu; Shaojing Li; Shuang Yue; Yan Yang
Journal:  Clin Rheumatol       Date:  2020-06-16       Impact factor: 2.980

Review 2.  IgA Nephropathy: An Interesting Autoimmune Kidney Disease.

Authors:  Arun Rajasekaran; Bruce A Julian; Dana V Rizk
Journal:  Am J Med Sci       Date:  2020-10-08       Impact factor: 2.378
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.